Clotrimazole as a pharmaceutical: past, present and future.

P.D. Crowley; H.C. Gallagher

doi:10.1111/jam.12554

journal article Open Access Jun 30, 2014

Clotrimazole as a pharmaceutical: past, present and future.

P.D. Crowley H.C. Gallagher

Journal of Applied Microbiology Vol. 117 No. 3 pp. 611-617 · Oxford University Press (OUP)

View at Publisher Save 10.1111/jam.12554

Topics

No keywords indexed for this article. Browse by subject →

References

53

[1]

Alsterholm "Antimicrobial activity of topical skin pharmaceuticals - an in vitro study" Acta Derm Venereol (2010) 10.2340/00015555-0840

[2]

Bartolommei "Clotrimazole inhibits the Ca2+-ATPase (SERCA) by interfering with Ca2+ binding and favoring the E2 conformation" J Biol Chem (2006) 10.1074/jbc.m510550200

[3]

Benzaquen "Clotrimazole inhibits cell proliferation in vitro and in vivo" Nat Med (1995) 10.1038/nm0695-534

[4]

Bilensoy "Thermosensitive vaginal gel formulation for the controlled release of clotrimazole via complexation to beta-cyclodextrin" J Control Release (2006) 10.1016/j.jconrel.2006.09.075

[5]

Brugnara "Clinical trials of new therapeutic pharmacology for sickle cell disease" Sante (2006)

[6]

Brugnara "Therapy with oral clotrimazole induces inhibition of the Gardos channel and reduction of erythrocyte dehydration in patients with sickle cell disease" J Clin Invest (1996) 10.1172/jci118537

[7]

Costa "Candida glabrata drug: H+ antiporter CgTpo3 (ORF CAGL0I10384g): role in azole drug resistance and polyamine homeostasis" J Antimicrob Chemother (2014) 10.1093/jac/dku1044

[8]

Cudmore "Treatment of infections caused by metronidazole-resistant Trichomonas vaginalis" Clin Microbiol Rev (2004) 10.1128/cmr.17.4.783-793.2004

[9]

Eaton "Reduction by dithionite ion of adducts of metmyoglobin with imidazole, pyridine, and derivatives" J Biol Chem (1978) 10.1016/s0021-9258(17)38190-5

[10]

Eaton "Reaction of imidazole and hydroquinone with oxymyoglobin" J Inorg Biochem (1979) 10.1016/s0162-0134(00)80279-2

[11]

Eliel (1994)

[12]

Ellepola "Oral candidal infections and antimycotics" Crit Rev Oral Biol Med (2000) 10.1177/10454411000110020301

[13]

Gbotosho "Inhibitors of second messenger pathways and Ca-induced exposure of phosphatidylserine in red blood cells of patients with sickle cell disease" Pflugers Arch (2013) 10.1007/s00424-00013-01343-00428

[14]

Gelone (2006)

[15]

Gemma "Design and synthesis of potent antimalarial agents based on clotrimazole scaffold: exploring an innovative pharmacophore" J Med Chem (2007) 10.1021/jm061429p

[16]

Gemma "Clotrimazole scaffold as an innovative pharmacophore towards potent antimalarial agents: design, synthesis, and biological and structure-activity relationship studies" J Med Chem (2008) 10.1021/jm701247k

[17]

Hicks "What's new in stable radical chemistry?" Org Biomol Chem (2007) 10.1039/b617142g

[18]

Hitchcock "Interaction of azole antifungal antibiotics with cytochrome P-450-dependent 14 alpha-sterol demethylase purified from Candida albicans" Biochem J (1990) 10.1042/bj2660475

[19]

Jan "Novel effects of clotrimazole on Ca2+ signaling in Madin Darby canine kidney cells" Life Sci (2000) 10.1016/s0024-3205(00)00558-0

[20]

Kalb "Contact dermatitis to clotrimazole" Cutis (1985)

[21]

Lorand "Recent advances in antifungal agents" Mini-Rev Med Chem (2007) 10.2174/138955707781662672

[22]

Malani "Changing epidemiology of rare mould infections" Drugs (2007) 10.2165/00003495-200767130-00001

[23]

Marichal "Biochemical basis for the activity and selectivity of oral antifungal drugs" Br J Clin Pract Suppl (1990)

[24]

Mishra "Pathogenicity and drug resistance in Candida albicans and other yeast species" Acta Microbiol Immunol Hung (2007) 10.1556/amicr.54.2007.3.1

[25]

Navarro "Synthesis and characterization of new palladium-clotrimazole and palladium-chloroquine complexes showing cytotoxicity for tumor cell lines in vitro" J Inorg Biochem (2006) 10.1016/j.jinorgbio.2005.10.013

[26]

Navarro "Synthesis, characterization, DNA interaction studies and anticancer activity of platinum-clotrimazole complexes" Transition Met Chem (2009) 10.1007/s11243-009-9276-y

[27]

Navas "Induction of cytochrome P4501A (CYP1A) by clotrimazole, a non-planar aromatic compound. Computational studies on structural features of clotrimazole and related imidazole derivatives" Life Sci (2004) 10.1016/j.lfs.2004.09.015

[28]

Odds "Antifungal agents: mechanisms of action" Trends Microbiol (2003) 10.1016/s0966-842x(03)00117-3

[29]

OSPAR Commission 2005 Hazardous Substance Series: Open background documentation on clotrimazole http://www.ospar.org/documents/dbase/publications/p00199/p00199_bd%20on%20clotrimazole.pdf

[30]

Oyama "Clotrimazole, an antifungal drug possessing diverse actions, increases the vulnerability to cadmium in lymphocytes dissociated from rat thymus" Toxicology (2006) 10.1016/j.tox.2006.09.007

[31]

Pasqualotto "Novel triazole antifungal drugs: focus on isavuconazole, ravuconazole and albaconazole" Curr Opin Investig Drugs (2010)

[32]

Pelletier "Emergence of resistance of Candida albicans to clotrimazole in human immunodeficiency virus-infected children: in vitro and clinical correlations" J Clin Microbiol (2000) 10.1128/jcm.38.4.1563-1568.2000

[33]

Podust "Crystal structure of cytochrome P450 14α-sterol demethylase (CYP51) from Mycobacterium tuberculosis in complex with azole inhibitors" Proc Natl Acad Sci (2001) 10.1073/pnas.061562898

[34]

Porsbring , T. Blanck , H. Tjellström , H. Backhaus , T. 2009 The pharmaceutical clotrimazole affects marine microalgal communities at picomolar concentrations SETAC Europe 19th Annual Meeting Gothenburg, Sweden http://swepubkbse/bib/swepub:oai:servicessciglooorg:113304?tab2=abs&language=en

[35]

Rittenhouse "The antifungal imidazole clotrimazole and its major in vivo metabolite are potent blockers of the calcium-activated potassium channel in murine erythroleukemia cells" J Membr Biol (1997) 10.1007/s002329900227

[36]

Robles-Escajeda "Analysis of the cytotoxic effects of ruthenium-ketoconazole and ruthenium-clotrimazole complexes on cancer cells" Cell Biol Toxicol (2013) 10.1007/s10565-013-9264-z

[37]

Santos "Formulation and in vitro evaluation of coconut oil-core cationic nanocapsules intended for vaginal delivery of clotrimazole" Colloids Surf B Biointerfaces (2014) 10.1016/j.colsurfb.2014.01.011

[38]

Shah "Clotrimazole analogues: effective blockers of the slow afterhyperpolarization in cultured rat hippocampal pyramidal neurones" Br J Pharmacol (2001) 10.1038/sj.bjp.0703895

[39]

Singh "Preparation and evaluation of buccal bioadhesive films containing clotrimazole" AAPS PharmSciTech (2008) 10.1208/s12249-008-9083-3

[40]

Sobel "Vulvovaginal candidosis" Lancet (2007) 10.1016/s0140-6736(07)60917-9

[41]

Song "The antifungal drug clotrimazole" Acta Crystallogr Sect C: Cryst Struct Commun (1998) 10.1107/s0108270198006386

[42]

Sweetman (2007)

[43]

Thapa "Inhibitory effects of clotrimazole on TNF-α-induced adhesion molecule expression and angiogenesis" Arch Pharm Res (2009) 10.1007/s12272-009-1416-6

[44]

Tian "Effects of the antifungal antibiotic clotrimazole on human cardiac repolarization potassium currents" Br J Pharmacol (2006) 10.1038/sj.bjp.0706590

[45]

Tiffert "Potent antimalarial activity of clotrimazole in in vitro cultures of Plasmodium falciparum" Proc Natl Acad Sci (2000) 10.1073/pnas.97.1.331

[46]

Tonglairoum "Fast-acting clotrimazole composited PVP/HPbetaCD nanofibers for oral candidiasis application" Pharm Res (2014) 10.1007/s11095-11013-11291-11091

[47]

Trivedi "Clotrimazole inhibits hemoperoxidase of Plasmodium falciparum and induces oxidative stress. Proposed antimalarial mechanism of clotrimazole" J Biol Chem (2005) 10.1074/jbc.m501563200

[48]

Valerio "Antifungal agents in current pediatric practice" Curr Infect Dis Rep (2013) 10.1007/s11908-013-0337-1

[49]

Vanić "Nanopharmaceuticals for improved topical vaginal therapy: can they deliver?" Eur J Pharm Sci (2013) 10.1016/j.ejps.2013.04.035

[50]

Weig "Genomics and the development of new diagnostics and anti-Candida drugs" Trends Microbiol (2007) 10.1016/j.tim.2007.05.007

Showing 50 of 53 references

Cited By

153

Clotrimazole‐loaded PLGA microparticles for local drug delivery to the vagina: Shape does matter

Yanyu Li, Jingting Luo · 2026

Animal Models and Experimental Medi...

Oxidative effects of the human antifungal drug clotrimazole on the eucaryotic model organism Saccharomyces cerevisiae

Berna Kavakcıoğlu Yardımcı, Leman Tarhan · 2024

Archiv f�r Mikrobiologie

Rising burden of superficial fungal infections in India and the role of Clotrimazole for optimal management

Poonam Shah, Shashank Bhargava · 2023

IP Indian Journal of Clinical and E...

Antimicrobial Peptide Synergies for Fighting Infectious Diseases

Jessica T. Mhlongo, Ayman Y. Waddad · 2023

Advanced Science

Review of Recurrent Otomycosis and Clotrimazole in Its Treatment

Mehreen Haq, Prasad Deshmukh · 2022

Cureus

Clotrimazole-Induced Oxidative Stress Triggers Novel Yeast Pkc1-Independent Cell Wall Integrity MAPK Pathway Circuitry

Ángela Sellers-Moya, Marcos Nuévalos · 2021

Journal of Fungi

Repurposing of Antimicrobial Agents for Cancer Therapy: What Do We Know?

Christina Pfab, Luisa Schnobrich · 2021

Cancers

Accelerated solvent extraction-gel permeation chromatography-gas chromatography-tandem mass spectrometry to rapid detection of clotrimazole residue in animal-derived food

Chao Han, Beizhen Hu · 2021

LWT

Metrics

153

Citations

53

References

Details

Published: Jun 30, 2014
Vol/Issue: 117(3)
Pages: 611-617
License: View

Authors

P

P.D. Crowley

School of Medicine and Medical Science; Conway Institute; University College Dublin; Belfield Dublin Ireland

H

H.C. Gallagher

School of Medicine and Medical Science; Conway Institute; University College Dublin; Belfield Dublin Ireland

Cite This Article

P.D. Crowley, H.C. Gallagher (2014). Clotrimazole as a pharmaceutical: past, present and future.. Journal of Applied Microbiology, 117(3), 611-617. https://doi.org/10.1111/jam.12554

Clotrimazole as a pharmaceutical: past, present and future.

You May Also Like